Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-acting octreotide for prevention of variceal rebleeding in portal hypertension
ChiCTR-TRC-14004384Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Apr 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4 trial of octreotide in Portal Hypertension (PH) and Cirrhosis (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoints: Hepatic venous pressure gradient and Vascular endothelial growth factor. Started Apr 2014; status: completed.
02
Drugs
octreotide
03
Conditions
Portal Hypertension (PH)Cirrhosis
Beyond the preview
Go deeper on ChiCTR-TRC-14004384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-14004384.